ONCOLYTICS BIOTECH INC (ONCY) Stock Analyst Earnings Estimates
NASDAQ:ONCY - Nasdaq - CA6823108759 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 886.30% | N/A 420.47% | N/A 256.53% | N/A 77.25% | N/A -9.19% | N/A 38.33% | N/A 12.39% | ||||||||||
| EBITDA YoY % growth | -18.43M | -14.32M 22.30% | -14.96M -4.47% | -15.59M -4.21% | -17.17M -10.13% | -19.88M -15.78% | -25.01M -25.80% | -25.78M -3.08% | -26.53M -2.91% | N/A -36.12% | N/A -10.05% | N/A -46.70% | N/A 17.26% | N/A 36.26% | N/A 391.76% | N/A 137.53% | N/A -14.97% | N/A 44.37% | N/A 39.89% | |
| EBIT YoY % growth | -18.59M | -14.5M 22.00% | -15.12M -4.28% | -15.68M -3.70% | -17.27M -10.14% | -20.37M -17.95% | -25.46M -24.99% | -26.23M -3.02% | -26.92M -2.63% | N/A -33.84% | N/A -4.55% | N/A -30.75% | N/A 49.91% | N/A 48.75% | N/A 770.34% | N/A 127.18% | N/A 11.28% | N/A 47.11% | N/A 14.15% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -1.90 | -1.14 40.00% | N/A -13.62% | -1.14 11.99% | -1.04 9.21% | -0.93 10.14% | -0.43 53.76% | -0.49 -13.95% | -0.44 10.20% | -0.41 6.82% | N/A -5.34% | N/A -12.09% | N/A 19.51% | N/A 45.23% | N/A 736.25% | N/A 106.40% | N/A 46.36% | N/A 30.99% | N/A 11.40% |
All data in CAD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.12 -142.14% | -0.12 -34.67% | -0.11 -11.10% | -0.11 7.42% | -0.11 12.41% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | -12.219M -44.68% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -10.839M -22.49% | N/A | N/A | N/A | N/A |
All data in CAD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.12 14.29% | -0.10 | -0.02 | -15.35% |
| Q2 2024 Q2Q % growth | -0.10 16.67% | -0.10 | 0.00 | 3.10% |
| Q1 2024 Q2Q % growth | -0.09 10.00% | -0.11 | 0.02 | 17.49% |
| Q4 2023 Q2Q % growth | -0.05 66.67% | -0.15 | 0.10 | 66.41% |
| Q3 2023 Q2Q % growth | -0.14 -75.00% | -0.11 | -0.03 | -33.28% |
| Q2 2023 Q2Q % growth | -0.12 -33.33% | -0.11 | -0.01 | -5.24% |
| Q1 2023 Q2Q % growth | -0.10 16.67% | -0.13 | 0.03 | 25.28% |
| Q4 2022 Q2Q % growth | -0.15 -7.14% | -0.10 | -0.05 | -53.17% |
| Q3 2022 Q2Q % growth | -0.08 11.11% | -0.11 | 0.03 | 27.82% |
| Q2 2022 Q2Q % growth | -0.09 30.77% | -0.11 | 0.02 | 16.46% |
| Q1 2022 Q2Q % growth | -0.12 7.69% | -0.15 | 0.03 | 18.99% |
| Q4 2021 Q2Q % growth | -0.14 36.36% | -0.13 | -0.01 | -9.43% |
| Q3 2021 Q2Q % growth | -0.09 43.75% | -0.14 | 0.05 | 37.83% |
| Q2 2021 Q2Q % growth | -0.13 23.53% | -0.12 | -0.01 | -7.26% |
| Q1 2021 Q2Q % growth | -0.13 -208.33% | -0.18 | 0.05 | 25.74% |
| Q4 2020 Q2Q % growth | -0.22 12.00% | -0.15 | -0.07 | -45.21% |
| Q3 2020 Q2Q % growth | -0.16 -6.67% | -0.14 | -0.02 | -13.15% |
| Q2 2020 Q2Q % growth | -0.17 34.62% | -0.14 | -0.03 | -24.68% |
| Q1 2020 Q2Q % growth | 0.12 144.44% | -0.25 | 0.37 | 147.52% |
| Q4 2019 Q2Q % growth | -0.25 | -0.15 | -0.10 | -65.02% |
| Q3 2019 Q2Q % growth | -0.15 | -0.22 | 0.07 | 32.49% |
| Q2 2019 Q2Q % growth | -0.26 | -0.26 | 0.00 | -0.95% |
| Q1 2019 Q2Q % growth | -0.27 | -0.29 | 0.02 | 7.82% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -20.52% | 0% | 0% |
| Revenue | N/A | -100% | N/A | N/A |